Related Experiment Videos
Potential source of error in official diazepam assays
Journal of Pharmaceutical Sciences
|April 1, 1978
Summary
A benzophenone hydrolysis product can interfere with the United States Pharmacopeia (USP) XIX spectrophotometric assay for diazepam. A small adjustment to the official method can correct this analytical error.
Area of Science:
- Analytical Chemistry
- Pharmaceutical Analysis
Background:
- The United States Pharmacopeia (USP) XIX provides a spectrophotometric method for determining diazepam content in dosage forms.
- Accurate quantification of active pharmaceutical ingredients is crucial for ensuring drug safety and efficacy.
Purpose of the Study:
- To identify potential sources of interference in the USP XIX spectrophotometric determination of diazepam.
- To propose a solution for mitigating interference from benzophenone hydrolysis products.
Main Methods:
- Investigated the potential interference of benzophenone hydrolysis products.
- Evaluated the impact of interference on the USP XIX spectrophotometric assay for diazepam.
- Proposed a minor adaptation to the official assay procedure.
Main Results:
- A benzophenone hydrolysis product was identified as a source of interference.
- The interference can lead to inaccurate diazepam quantification.
- A simple modification to the assay procedure can resolve the interference issue.
Conclusions:
- Benzophenone hydrolysis products can interfere with the USP XIX spectrophotometric determination of diazepam.
- The proposed adaptation to the official assay method effectively corrects for this interference.
- Ensuring assay accuracy requires awareness of potential interfering substances.